Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06963723 · ClinicalTrials.gov registry record · NA

Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer

A NA study of Advanced Cancer and Metastatic Cancer, sponsored by Alliance Foundation Trials.

Recruiting
Registry status
NA
Development phase
1,000
Enrollment target
5
Study locations

NCT06963723: Recruiting NA study of Advanced Cancer and Metastatic Cancer, sponsored by Alliance Foundation Trials.

NCT06963723 is a NA study of Advanced Cancer and Metastatic Cancer that is actively recruiting participants, run by Alliance Foundation Trials. The registered enrollment target is 1,000 participants, above the 238-participant average among 122 other Advanced Cancer trials with a reported enrollment target (320% higher). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06963723, a NA study of Advanced Cancer and Metastatic Cancer, is actively recruiting participants, sponsored by Alliance Foundation Trials.

RECRUITING
Registry status
NA
Development phase
1,000 participants
Enrollment target
5
Study locations

Study Summary

The study aims to determine whether monthly remote digital financial hardship screening among adults with advanced/metastatic cancer, undergoing outpatient systemic therapy with non-curative intent, improves patient-centered outcomes, including financial worry, health-related quality of life (HRQoL), symptom burden, patient-reported cancer treatment adherence, and exploratory outcomes of overall survival, patient-reported economic burden, patient-reported support received, patient-reported financial coping strategies, and health insurance literacy.

Primary Outcome

Patient-reported financial worry will be measured by the Functional Assessment of Chronic Illness Therapy-Comprehensive Score for Financial Toxicity (FACIT-COST) total scale. Possible score range: 0 to 44, with higher scores indicating better outcomes

Conditions Studied

Advanced Cancer Metastatic Cancer

Interventions

  • OTHER Enhanced Usual Care
  • OTHER Financial Hardship Screening

Study Locations (5)

New Hampshire

  • New Hampshire Oncology-Hematology, PA - Concord
  • Solinsky Center for Cancer Care - Manchester

Arizona

  • Dignity Health - Phoenix

New York

  • New York City Health and Hospitals - New York

Other

  • Pan American Center for Oncology Trials - San Juan

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2025-07-01
Est. Completion 2029-04-01
Phase NA
Alliance Foundation Trials

20 total trials

What NCT06963723 shows while recruiting

NCT06963723 is an interventional study that assigns participants to a tested intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 238-participant average among 122 other Advanced Cancer trials with a reported enrollment target (320% higher).

The record links to 2 conditions, with Advanced Cancer appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Usual Care is the first listed.

NCT06963723 lists 5 locations in 4 states (New Hampshire, Arizona, New York).

Frequently Asked Questions

What is clinical trial NCT06963723 about?

NCT06963723 is a clinical study titled "Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer". The study aims to determine whether monthly remote digital financial hardship screening among adults with advanced/metastatic cancer, undergoing outpatient systemic therapy with non-curative intent, improves patient-centered outcomes, including financial worry, health-related quality of life (HRQoL)...

What is the current status of trial NCT06963723?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,000 participants. The study started on 2025-07-01. Estimated completion is 2029-04-01.

What conditions does trial NCT06963723 study?

This clinical trial studies the following conditions: Advanced Cancer, Metastatic Cancer.

What interventions are being tested in trial NCT06963723?

The interventions under investigation include: Enhanced Usual Care (OTHER), Financial Hardship Screening (OTHER).

Who is sponsoring clinical trial NCT06963723?

This trial is sponsored by Alliance Foundation Trials, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06963723 being conducted?

This trial has 5 study locations across Arizona, New Hampshire, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Advanced Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06963723's enrollment target sits among peer trials

1,000 3rd of 122 higher than 120 of 122 other Advanced Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Advanced Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06963723

Source: ClinicalTrials.gov NCT06963723, the US trial registry maintained by the National Library of Medicine. NCT06963723 (large enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.